These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 4765368

  • 1. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
    Weissman IL.
    J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
    [No Abstract] [Full Text] [Related]

  • 2. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L, Hunter N, Mason K, Withers HR.
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract] [Full Text] [Related]

  • 3. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA, Prehn RT.
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract] [Full Text] [Related]

  • 4. Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue.
    Vaage J.
    Cancer Res; 1971 Nov; 31(11):1655-62. PubMed ID: 5121668
    [No Abstract] [Full Text] [Related]

  • 5. Normal tissue antigens of tumor cells.
    Milas L, Suit HD.
    Tex Rep Biol Med; 1969 Nov; 27(2):467-9. PubMed ID: 4900374
    [No Abstract] [Full Text] [Related]

  • 6. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.
    Townsend SE, Su FW, Atherton JM, Allison JP.
    Cancer Res; 1994 Dec 15; 54(24):6477-83. PubMed ID: 7527298
    [Abstract] [Full Text] [Related]

  • 7. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E, Klein G.
    Cell Immunol; 1972 Sep 15; 5(1):201-8. PubMed ID: 5078988
    [No Abstract] [Full Text] [Related]

  • 8. The development of cellular immunity to tumor cells.
    Cerilli J, Smith MC.
    Surg Gynecol Obstet; 1972 May 15; 134(5):739-45. PubMed ID: 5064081
    [No Abstract] [Full Text] [Related]

  • 9. Effect of dietary amino acids on tumour growth and cell-mediated immune responses.
    Bounous G, Sadarangani C, Pang KC, Kongshavn PA.
    Clin Invest Med; 1981 May 15; 4(2):109-15. PubMed ID: 7026098
    [No Abstract] [Full Text] [Related]

  • 10. Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.
    Vaage J.
    Cancer Res; 1973 Aug 15; 33(8):1957-65. PubMed ID: 4720805
    [No Abstract] [Full Text] [Related]

  • 11. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M, Wanebo HJ, Alfieri A, Hahn EW.
    AJR Am J Roentgenol; 1977 Jun 15; 128(6):1027-9. PubMed ID: 414534
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas.
    Iglehart JD, Ward EC, Thiel K, Huper G, Geier SS, Bolognesi DP.
    J Natl Cancer Inst; 1981 Jul 15; 67(1):107-15. PubMed ID: 6942181
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
    Ruddle NH, Armstrong MY, Richards FF.
    J Immunol; 1974 Feb 15; 112(2):706-15. PubMed ID: 4149884
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M, Suit HD.
    Cancer Res; 1974 Apr 15; 34(4):672-8. PubMed ID: 4814987
    [No Abstract] [Full Text] [Related]

  • 18. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM, Whitten HD, Lewis GK, Watson ES.
    Transplant Proc; 1973 Mar 15; 5(1):961-7. PubMed ID: 4695960
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.